Weiss Multi-Strategy Advisers’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-20,000	Closed	-$318K	–	591
2015 Q4	$318K	Hold	20,000	–	–	0.02%	327
2015 Q3	$307K	Sell	20,000 -1,000	-5%	-$21.6K	0.01%	352
2015 Q2	$511K	Buy	21,000 +400	+2%	+$9.58K	0.02%	379
2015 Q1	$479K	Buy	20,600 +600	+3%	+$15.9K	0.02%	371
2014 Q4	$502K	Sell	20,000 -5,000	-20%	-$147K	0.02%	342
2014 Q3	$778K	Sell	25,000 -40,000	-62%	-$1.08M	0.02%	405
2014 Q2	$1.68M	Sell	65,000 -10,000	-13%	-$222K	0.04%	356
2014 Q1	$1.75M	Buy	75,000 +5,000	+7%	+$109K	0.04%	377
2013 Q4	$1.78M	Sell	70,000 -31,000	-31%	-$700K	0.04%	347
2013 Q3	$2.06M	Buy	101,000 +51,000	+102%	+$1.14M	0.04%	334
2013 Q2	$1.05M	Buy	+50,000	New	+$894K	0.03%	381

Other funds holding SGNT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SGNT Position: Q1 2016 in Review

Weiss Multi-Strategy Advisers sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2016, closing a stake of 20,000 shares — an estimated $318K sold.

Weiss Multi-Strategy Advisers first reported a position in SGNT in Q2 2013 and held it in 11 quarters. The position peaked at $2.06M in Q3 2013. 136 funds tracked by Wall St. Rank hold SGNT as of Q1 2016.

Weiss Multi-Strategy Advisers reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016, an estimated $318K.
Weiss Multi-Strategy Advisers first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
Weiss Multi-Strategy Advisers's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.06M in Q3 2013.
136 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2016, filed 16 May 2016.